Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.39B | 1.39B | 1.35B | 1.09B | 1.24B | Gross Profit |
911.37M | 662.60M | 689.93M | 553.44M | 715.02M | EBIT |
382.38M | 368.81M | 383.79M | 302.87M | 453.79M | EBITDA |
596.91M | 592.40M | 602.84M | 474.13M | 617.30M | Net Income Common Stockholders |
315.80M | 315.64M | 305.25M | 284.63M | 360.16M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
567.40M | 656.85M | 454.37M | 532.89M | 671.09M | Total Assets |
1.22B | 1.30B | 1.28B | 1.48B | 1.30B | Total Debt |
268.73M | 240.35M | 311.07M | 261.60M | 252.00M | Net Debt |
-298.68M | -206.28M | -143.08M | -236.98M | -314.45M | Total Liabilities |
725.00M | 684.02M | 786.93M | 795.52M | 620.25M | Stockholders Equity |
497.51M | 612.27M | 494.27M | 684.85M | 679.00M |
Cash Flow | Free Cash Flow | |||
445.50M | 533.81M | 372.16M | 527.69M | 549.00M | Operating Cash Flow |
497.12M | 560.55M | 516.71M | 605.91M | 645.44M | Investing Cash Flow |
162.56M | -222.51M | 8.05M | -300.82M | -75.22M | Financing Cash Flow |
-520.97M | -335.02M | -565.97M | -394.41M | -330.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $32.93B | 11.91 | 14.56% | 5.03% | -5.37% | 6.28% | |
73 Outperform | HK$2.94B | 10.13 | 58.52% | 12.22% | -9.98% | -12.36% | |
66 Neutral | HK$20.01B | 21.54 | 25.73% | ― | 168.87% | 150.80% | |
62 Neutral | $6.88B | 11.32 | 2.90% | 3.87% | 2.70% | -24.57% | |
50 Neutral | HK$404.53M | ― | -57.25% | ― | 95.39% | 30.86% | |
45 Neutral | $14.78B | 84.76 | 0.96% | ― | 1.01% | ― | |
36 Underperform | HK$161.78M | ― | -7.42% | ― | 10.93% | -159.62% |
Perfect Medical Health Management Limited has announced the grant of 3,768,000 share options to eligible employees under its share option scheme. This initiative, effective from January 7, 2025, aims to recognize past contributions and incentivize employees, aligning their interests with the company’s long-term goals and shareholder value. The share options, priced at HK$2.208 each, are intended to motivate continued commitment and performance, reflecting the company’s strategy to enhance employee engagement and loyalty.